Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sequential Paclitaxel/Carboplatin then Gemzar/Carboplatin in Ovarian Cancer
NCT00490711Phase 2Completed
- Sponsor
- Eli Lilly and Company
- Start
- Jul 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of gemcitabine in epithelial ovarian cancer (EOC), sponsored by Eli Lilly and Company. Started Jul 2003; status: completed.
02
Drugs
gemcitabine
03
Conditions
epithelial ovarian cancer (EOC)
Beyond the preview
Go deeper on NCT00490711.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00490711.